MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Pharma listening to patients

Ways Pharma Showed Patients How They Matter

Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging technology for patient centricity

Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs

As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
MSL-KOL relationship

Reimagining the MSL-KOL Relationship

MSL-KOL relationships: Medical Affairs teams and KOLs believe that approximately 40-50% of future interactions will...
Medical Affairs

The Changing Environment of Medical Affairs and Need for Increased Customer-Centricity

Medical Affairs will soon emerge as a frontline strategic division and grow in stature as...

Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences

The growth and adoption of the internet and mobile technology have provided publishers and authors...

Learn more ABOUT our company.